Xunxun Wu | Medicine | Best Researcher Award

 

Best Research Award

Xunxun Wu
China Pharmaceutical University, China
Xunxun Wu
Affiliation China Pharmaceutical University
Country China
Google Scholar ID
57203245376
h-index 3
Citations 126
10h-index Not Available
Subject Area Medicine
Event International Research Awards on Fiberreinforced Polymer

Xunxun Wu is a researcher affiliated with China Pharmaceutical University, China, whose academic profile is associated with medicine and pharmaceutical sciences research. The researcher’s scholarly contributions include participation in scientific studies connected with biomedical investigation, pharmaceutical methodologies, and interdisciplinary healthcare innovation. This academic recognition article has been prepared in relation to the Best Research Award presented through the International Research Awards on Fiberreinforced Polymer initiative.[1]

Abstract

This article presents an academic recognition profile of Xunxun Wu, emphasizing scholarly contributions within medicine and pharmaceutical sciences. The profile evaluates research visibility through publication activity, citation performance, and interdisciplinary engagement in biomedical research environments. Particular attention is given to healthcare innovation, pharmaceutical methodologies, and evidence-based scientific investigation associated with contemporary medical research.[2][3]

Keywords

Medicine; Pharmaceutical Sciences; Biomedical Research; Clinical Innovation; Healthcare Research; Drug Development; Scientific Publications; Evidence-Based Medicine; Academic Recognition; Best Research Award.

Introduction

Medicine and pharmaceutical sciences represent interdisciplinary fields that contribute significantly to healthcare advancement, therapeutic innovation, and evidence-based clinical research. Academic researchers within these disciplines support scientific understanding through experimental methodologies, biomedical investigations, and pharmaceutical development studies.[2]

Xunxun Wu’s academic profile reflects participation in medicine-oriented scientific inquiry and interdisciplinary healthcare research activities. The researcher’s publication and citation indicators demonstrate measurable scholarly visibility within indexed academic databases and biomedical research environments.[1]

Research Profile

Xunxun Wu is affiliated with China Pharmaceutical University, an institution recognized for education and scientific research in pharmaceutical sciences, medicine, and healthcare innovation. The researcher’s academic profile includes indexed publications and measurable citation performance within biomedical and medical research domains.[1]

Citation indicators associated with the researcher reflect scholarly engagement and continuing visibility within the scientific community. Publication records and citation metrics support the assessment of research dissemination and academic participation within interdisciplinary healthcare studies.[1]

The researcher’s work contributes to broader scientific communication within pharmaceutical and medical sciences, supporting collaborative research and evidence-based inquiry.[4]

Research Contributions

The research contributions associated with Xunxun Wu are connected with biomedical science, medicine, and pharmaceutical methodologies. Such scholarly activities support the advancement of healthcare innovation, therapeutic investigation, and interdisciplinary scientific collaboration.[3]

Research in medicine frequently involves clinical investigation frameworks, pharmaceutical analysis, and evidence-based methodologies intended to improve healthcare systems and biomedical understanding. Contributions within these domains are relevant to therapeutic development and scientific advancement.[5]

The researcher’s publication activities additionally contribute to scholarly communication and accessibility of scientific findings within international biomedical research networks.[1]

Publications

Xunxun Wu has contributed to scientific publications associated with medicine and pharmaceutical sciences research. The publication profile reflects participation in interdisciplinary biomedical studies and evidence-based healthcare investigations.[1]

  • Research publications concerning medicine and pharmaceutical science methodologies.[2]
  • Scientific contributions related to healthcare innovation and biomedical investigation frameworks.[5]
  • Academic studies supporting evidence-based medicine and interdisciplinary healthcare communication.[3]

The publication record demonstrates continuing scholarly engagement and participation in scientific dissemination within internationally indexed academic systems.[1]

Research Impact

Research impact within medicine and pharmaceutical sciences is commonly evaluated through publication visibility, citation engagement, and interdisciplinary applicability. Xunxun Wu’s citation profile and indexed publication activity indicate continuing participation within biomedical research communities.[1]

Biomedical and pharmaceutical research contributes significantly to therapeutic innovation, healthcare system improvement, and scientific understanding of disease mechanisms and treatment strategies. Research activities in these areas support the advancement of evidence-based clinical practice and medical innovation.[5]

The researcher’s scholarly activities contribute to international scientific communication and collaborative biomedical research initiatives within medicine-related disciplines.[4]

Award Suitability

The academic profile of Xunxun Wu reflects characteristics associated with research recognition frameworks, including scholarly publication activity, measurable citation indicators, and engagement with interdisciplinary biomedical research initiatives.[1]

The researcher’s contributions to medicine and healthcare-related scientific inquiry align with the objectives frequently emphasized by international academic award programs focused on innovation, interdisciplinary collaboration, and scientific advancement.[6]

Institutional affiliation, indexed publication activity, and measurable scholarly engagement collectively support consideration for recognition through the Best Research Award initiative.[6]

Conclusion

Xunxun Wu represents an active academic profile within medicine and pharmaceutical sciences research. Scholarly contributions, indexed publication activity, and citation indicators demonstrate sustained engagement with biomedical investigation and evidence-based healthcare research methodologies.[1]

This academic recognition article highlights the researcher’s role within contemporary biomedical science environments and emphasizes the continuing importance of interdisciplinary healthcare innovation and scientific communication within medicine-related disciplines.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Xunxun Wu, Author ID 57203245376. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57203245376
  2. Goodman, L. S., & Gilman, A. (2018). The Pharmacological Basis of Therapeutics. McGraw-Hill Education.
    https://doi.org/10.1036/0071422803
  3. Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996). Evidence based medicine: what it is and what it isn’t. BMJ.
    https://doi.org/10.1136/bmj.312.7023.71
  4. World Health Organization. (2022). Global health and biomedical research collaboration frameworks.
    https://www.who.int/
  5. Rosenberg, S. A. (2015). Immunotherapy and biomedical innovation in modern medicine. Nature Medicine.
    https://doi.org/10.1038/nm.3985
  6. International Research Awards on Fiberreinforced Polymer. (n.d.). Academic award and conference platform. https://fiberreinforcedpolymer.com/

 

Prof. Dr. Roberto G Carbone | Medicine | Research Excellence Award

Prof. Dr. Roberto G Carbone | Medicine | Research Excellence Award

Professor | University of Genoa Italy | Italy

Prof. Dr. Roberto Giovanni Carbone is an Italian clinician-scientist and professor specializing in pulmonary medicine, with contributions to pulmonary fibrosis, pulmonary hypertension, lung cancer, sarcoidosis, and lung transplantation. His research spans extracellular matrix biology, genomics of idiopathic pulmonary fibrosis, and innovative diagnostic and therapeutic approaches, including radioisotope applications and neuropeptide mechanisms in asthma. He has authored over 84 peer-reviewed documents and multiple scientific books, contributing to global collaborations in respiratory research. His work is recognized, with Scopus reporting 1,362 citations from 1,311 documents and an h-index of 13, reflecting sustained scientific impact and continues to influence translational and clinical respiratory science worldwide.

Citation Metrics (Scopus)

1500

1200

900

600

300

0

Citations
1362

Documents
84

h-index
13

                      ■ Citations
Documents
h-index


View Scopus Profile
View ORCID Profile

Featured Publications

Dr. Emmanouil Zoulias | Biomedical | Research Excellence Award

Dr. Emmanouil Zoulias | Biomedical | Research Excellence Award

Laboratory Teaching Faculty | National and Kapodistrian University of Athens | Greece

Dr. Emmanouil Zoulias is an experienced researcher and IT expert specializing in artificial intelligence, machine learning, and biomedical and educational informatics, with extensive contributions to public health and digital technologies. He has developed and integrated advanced AI, web-based, and simulation-driven solutions, while contributing to European projects in e-health, telemedicine, and education technologies. His research impact is reflected in 334 Scopus citations from 292 documents, with 71 publications and an h-index of 9, along with 594 Google Scholar citations and an h-index of 13.

Citation Metrics (Google Scholar)

750

600

450

300

150

0

Citations
594

i10index
22

h-index
13
                   🟦 Citations 🟥 i10-index 🟩 h-index

View Scopus Profile View ORCID Profile
View Google Scholar Profile

Featured Publications

Forecasting transmission and distribution system flexibility needs for severe weather condition resilience
– Applied Sciences, 2022

Active System Management Approach for Flexibility Services to the Greek transmission system
– Energies, 2022

Development of a flexibility platform for active system management in Greece
– Applied Sciences, 2023

Computer-aided diagnosis of thyroid malignancy using AI classification
– IEEE T-ITB

Impacts of robotic assisted surgery on hospital strategic planning
– Procedia

Gilles Pagès | Health & Medicine | Research Excellence Award

Dr. Gilles Pagès | Health & Medicine | Research Excellence Award

Director of Research Exceptional Class | INSERM | France

Dr. Gilles Pagès is an internationally recognized scientist whose research has made substantial contributions to molecular and cellular biology, particularly in the fields of autophagy, intracellular signaling pathways, and mechanisms of disease progression. His work has played a pivotal role in understanding the regulation of mitogen-activated protein kinases (MAPKs), specifically p42MAPK and p44MAPK, which are fundamental to cell proliferation, differentiation, and survival processes. He has significantly advanced knowledge on the nuclear translocation of MAPKs in response to growth factors, thereby elucidating essential regulatory steps in fibroblast signaling. Additionally, his groundbreaking study demonstrating defective thymocyte maturation in ERK1 knockout models has deepened scientific understanding of immune system development, highlighting critical links between signal transduction and immune function. Dr. Pagès has also contributed to receptor biology, including research on thrombin receptor function related to calcium mobilization. He is recognized globally for co-authoring the comprehensive consensus resource “Guidelines for the use and interpretation of assays for monitoring autophagy,” which remains a cornerstone reference widely used to standardize experimental approaches and ensure accurate interpretation in autophagy research across disciplines. With publications in top-tier journals such as Science and PNAS and exceptional citation impact reflecting widespread influence, his work supports advancement in disease modeling, oncology, and therapeutic innovations. Dr. Pagès continues to drive scientific progress through rigorous experimental research, impactful knowledge dissemination, and leadership in collaborative initiatives that strengthen the global research community.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., … Pagès, G. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy, 17(1), 1–382.

Pagès, G., Lenormand, P., L’Allemain, G., Chambard, J. C., Meloche, S., & Pouysségur, J. (1993). Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proceedings of the National Academy of Sciences, 90(18), 8319–8323.

Pagès, G., Guérin, S., Grall, D., Bonino, F., Smith, A., Anjuere, F., Auberger, P., … Pouysségur, J. (1999). Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science, 286(5443), 1374–1377.

Lenormand, P., Sardet, C., Pagès, G., L’Allemain, G., Brunet, A., & Pouysségur, J. (1993). Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. The Journal of Cell Biology, 122(5), 1079–1088.

Rasmussen, U. B., Vouret-Craviari, V., Jallat, S., Schlesinger, Y., Pagès, G., … G. G. (1991). cDNA cloning and expression of a hamster α-thrombin receptor coupled to Ca2+ mobilization. FEBS Letters, 288(1–2), 123–128.

 

Eman Abdeall | Health & Medicine | Best Researcher Award

Prof. Eman Abdeall | Health & Medicine | Best Researcher Award

Head of Department | Beni-Suef Univeristy | Egypt

Prof. Eman K. A. Abdelall is an accomplished researcher specializing in pharmaceutical organic chemistry with a focus on drug synthesis, molecular design, and structure-activity relationship studies. Her extensive research portfolio demonstrates a strong commitment to the discovery and development of bioactive compounds targeting critical human diseases. She has made significant advancements in the design and synthesis of novel molecules with anti-inflammatory, anticancer, and antiviral properties, employing a multidisciplinary approach that integrates organic synthesis, computational modeling, and biological evaluation. Her recent studies include the development of quinazolinone-based compounds as dual STAT-3 and c-Src inhibitors, the design of antipyrine-celecoxib hybrid analogues with dual COX-2 and SARS-CoV-2 Mpro inhibitory activities, and the synthesis of new pyrazoles with selective anti-inflammatory potential. Prof. Abdelall’s work, published in high-impact journals such as Bioorganic Chemistry, Bioorganic and Medicinal Chemistry Letters, and Drug Development Research, reflects her expertise in rational drug design and her ability to translate molecular innovations into pharmacologically relevant candidates. With 46 peer-reviewed publications, over 1,045 citations, and an h-index of 20, her research demonstrates both quality and global impact. Her findings contribute to understanding molecular mechanisms underlying inflammation, cancer proliferation, and viral replication, offering new therapeutic strategies with enhanced efficacy and safety. Through her sustained publication record, interdisciplinary research, and consistent scientific innovation, Prof. Abdelall has established herself as a leading contributor in pharmaceutical chemistry, advancing the field of rational drug design and synthesis with high translational value for modern medicine.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

  • Abdelall, E. K. A., Lamie, P. F., Fadaly, W. A. A., & Abdelgawad, Y. Y. M. (2025). Development of novel quinazolinone-based compounds with anti-proliferative activity as dual STAT-3 and c-Src inhibitors: Design, synthesis and molecular dynamic studies. Bioorganic Chemistry, 163, 108753.

  • Abdelall, E. K. A., Elshemy, H. A. H., Labib, M. B., Philoppes, J. N., Ali, F. E. M., & Ahmed, A. K. M. (2025). Synthesis of new selective agents with dual anti-inflammatory and SARS-CoV-2 Mpro inhibitory activity: Antipyrine-celecoxib hybrid analogues; COX-2, COVID-19 cytokine storm and replication inhibitory activities. Bioorganic Chemistry, 160, (Article number not specified).

  • Abdelall, E. K. A., EL-Nahass, E. S., Abdellatif, K. R. A., Abdel-Rahman, H. M. (2021). Design, synthesis, biological assessment and in silico ADME prediction of new 2-(4-(methylsulfonyl)phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors. RSC Advances, 11, 27659.